Resurrecting Clinical Pharmacology As a Context for Alzheimer Disease Drug Development

Author(s): Robert E. Becker, Latha K. Unni, Nigel H. Greig

Journal Name: Current Alzheimer Research

Volume 6 , Issue 1 , 2009

Become EABM
Become Reviewer


Commercial priorities have been identified as negative factors in drug development. We trace the problem to inattention to sound clinical pharmacology practices. When properly applied, clinical pharmacology and associated drug development sciences can, hand in hand, facilitate success in commercial drug development.

Keywords: Clinical Pharmacology, Alzheimer Disease, Drug Development, acetylcholinesterase (AChE) inhibition, cytoplasmic AChE

promotion: free to download

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2009
Page: [79 - 81]
Pages: 3
DOI: 10.2174/156720509787313916

Article Metrics

PDF: 37